ADC/mAb · mAb
Bevacizumab
Bevacizumab is an anti-VEGF monoclonal antibody used across multiple solid tumors. BOOKPHARM supplies bevacizumab biosimilar through technology transfer and supports out-licensing.
Supply offerings
| Business line | Business model | Regulatory status |
|---|---|---|
| FDFADC/mAb | License-out | NMPA approval |
| APImAb | Tech Transfer + Supply | NMPA approval |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied. Availability is subject to regulatory approval in the buyer's jurisdiction.